Patents by Inventor Gino Villetti

Gino Villetti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240165203
    Abstract: The present invention relates to a combined therapy for use in treatment and prevention of treatment and prevention of brain injury, in particular ischemic and/or hypoxic brain lesions, including but not limited to hypoxic-ischemic encephalopathy, preferably in a neonatal subject either at term or at preterm.
    Type: Application
    Filed: March 25, 2022
    Publication date: May 23, 2024
    Applicant: CHIESI FARMACEUTICI S.P.A.
    Inventors: Bruno Pietro IMBIMBO, Gino VILLETTI, Fabrizio FACCHINETTI, Elisa LANDUCCI, Dalila MANGO
  • Publication number: 20220401517
    Abstract: The present invention provides a non-natural polypeptide for use in treatment and/or prevention of an ophthalmic disorder in a mammalian subject. Administration of the polypeptide is well tolerated by the mammal. The non-natural polypeptide is provided at high purity.
    Type: Application
    Filed: September 15, 2020
    Publication date: December 22, 2022
    Inventors: Bruno Pietro IMBIMBO, Gino VILLETTI
  • Publication number: 20220218678
    Abstract: The present invention relates to the use of agents, which are 1-phenyl-2-pyridinyl alkyl alcohol derivatives, for the prevention and/or treatment of cystic fibrosis in a subject, wherein the subject is characterized by at least one mutation in the gene encoding the CFTR protein, wherein the at least one mutation is causative for incorrect folding and/or processing of the CFTR protein. By the use of the compound according to the present invention, cystic fibrosis in the subject may be prevented or treated. The agent to be used according to the present invention has the capacity to restore the presence of the mutant CFTR protein at the cell surface, and thus act as CFTR correctors. The agent to be used according to the present invention may be administered to a subject in need thereof alone or in combination therapy with other agents, and is suitably administered by inhalation.
    Type: Application
    Filed: March 31, 2022
    Publication date: July 14, 2022
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Gino VILLETTI, Serena BERTOLINI, Claudio SORIO
  • Publication number: 20220064243
    Abstract: The present invention provides a non-natural polypeptide for the treatment or prevention of skin disorders in a mammal. Administration of the polypeptide is well tolerated by the mammal. The non-natural polypeptide is provided at high purity.
    Type: Application
    Filed: September 17, 2019
    Publication date: March 3, 2022
    Inventors: Gino VILLETTI, Bruno Pietro IMBIMBO, Laura CALZÀ
  • Publication number: 20210038575
    Abstract: The present invention relates to the use of agents, which are 1-phenyl-2-pyridinyl alkyl alcohol derivatives, for the prevention and/or treatment of cystic fibrosis in a subject, wherein the subject is characterized by at least one mutation in the gene encoding the CFTR protein, wherein the at least one mutation is causative for incorrect folding and/or processing of the CFTR protein. By the use of the compound according to the present invention, cystic fibrosis in the subject may be prevented or treated. The agent to be used according to the present invention has the capacity to restore the presence of the mutant CFTR protein at the cell surface, and thus act as CFTR correctors. The agent to be used according to the present invention may be administered to a subject in need thereof alone or in combination therapy with other agents, and is suitably administered by inhalation.
    Type: Application
    Filed: December 19, 2018
    Publication date: February 11, 2021
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Gino VILLETTI, Serena BERTOLINI, Claudio SORIO
  • Patent number: 9931327
    Abstract: Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols are useful as inhibitors of the phosphodiesterase 4 (PDE4) enzyme and the treatment of certain conditions such as COPD.
    Type: Grant
    Filed: September 24, 2015
    Date of Patent: April 3, 2018
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Elisabetta Armani, Gabriele Amari, Laura Carzaniga, Carmelida Capaldi, Oriana Esposito, Gino Villetti, Renato De Fanti
  • Publication number: 20160008338
    Abstract: Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols are useful as inhibitors of the phosphodiesterase 4 (PDE4) enzyme and the treatment of certain conditions such as COPD.
    Type: Application
    Filed: September 24, 2015
    Publication date: January 14, 2016
    Applicant: Chiesi Farmaceutici S.p.A.
    Inventors: Elisabetta ARMANI, Gabriele Amari, Laura Carzaniga, Carmelida Capaldi, Oriana Esposito, Gino Villetti, Renato De Fanti
  • Patent number: 9150489
    Abstract: Derivatives of 1-(2-fluorobiphenyl-4-yl)-alkyl carboxylic acid are capable of stabilizing the tetrameric native state of transthyretin for the prophylaxis and treatment of amyloidosis.
    Type: Grant
    Filed: April 21, 2011
    Date of Patent: October 6, 2015
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Bruno Pietro Imbimbo, Gino Villetti, Rodolfo Berni
  • Publication number: 20140057882
    Abstract: Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols are useful as inhibitors of the phosphodiesterase 4 (PDE4) enzyme and the treatment of certain conditions such as COPD.
    Type: Application
    Filed: October 8, 2013
    Publication date: February 27, 2014
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Elisabetta ARMANI, GABRIELE AMARI, LAURA CARZANIGA, CARMELIDA CAPALDI, ORIANA ESPOSITO, GINO VILLETTI, RENATO DE FANTI
  • Publication number: 20130005716
    Abstract: Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols are useful as inhibitors of the phosphodiesterase 4 (PDE4) enzyme and the treatment of certain conditions such as COPD.
    Type: Application
    Filed: June 5, 2012
    Publication date: January 3, 2013
    Applicant: Chiesi Farmaceutici S.p.A.
    Inventors: Elisabetta Armani, Gabriele Amari, Laura Carzaniga, Carmelida Capaldi, Oriana Esposito, Gino Villetti, Renato De Fanti
  • Patent number: 8314268
    Abstract: 1-Phenylalkanecarboxylic acid derivatives, the processes for the preparation thereof and the use thereof in the treatment and/or prevention of neurodegenerative diseases such as Alzheimer's disease.
    Type: Grant
    Filed: August 8, 2011
    Date of Patent: November 20, 2012
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Luca Raveglia, Ilaria Peretto, Stefano Radaelli, Bruno Pietro Imbimbo, Andrea Rizzi, Gino Villetti
  • Publication number: 20120022163
    Abstract: Derivatives of 1-(2-fluorobiphenyl-4-yl)-cyclopropanecarboxylic acid are useful for the prevention and/or treatment of prion diseases in animals and humans.
    Type: Application
    Filed: June 6, 2011
    Publication date: January 26, 2012
    Applicant: Chiesi Farmaceutici S.p.A.
    Inventors: Bruno Pietro Imbimbo, Gino Villetti, Giorgio Poli
  • Publication number: 20110288175
    Abstract: 1-Phenylalkanecarboxylic acid derivatives, the processes for the preparation thereof and the use thereof in the treatment and/or prevention of neurodegenerative diseases such as Alzheimer's disease.
    Type: Application
    Filed: August 8, 2011
    Publication date: November 24, 2011
    Applicant: Chiesi Farmaceutici S.p.A.
    Inventors: Luca RAVEGLIA, Ilaria Peretto, Stefano Radaelli, Bruno Pietro Imbimbo, Andrea Rizzi, Gino Villetti
  • Publication number: 20110263711
    Abstract: Derivatives of 1-(2-fluorobiphenyl-4-yl)-alkyl carboxylic acid are capable of stabilizing the tetrameric native state of transthyretin for the prophylaxis and treatment of amyloidosis.
    Type: Application
    Filed: April 21, 2011
    Publication date: October 27, 2011
    Applicant: Chiesi Farmaceutici S.p.A.
    Inventors: Bruno Pietro IMBIMBO, Gino Villetti, Rodolfo Berni
  • Patent number: 8022250
    Abstract: 1-Phenylalkanecarboxylic acid derivatives, the processes for the preparation thereof and the use thereof in the treatment and/or prevention of neurodegenerative diseases such as Alzheimer's disease.
    Type: Grant
    Filed: December 24, 2009
    Date of Patent: September 20, 2011
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Luca Raveglia, Ilaria Peretto, Stefano Radaelli, Bruno Pietro Imbimbo, Andrea Rizzi, Gino Villetti
  • Patent number: 7968724
    Abstract: The invention provides inhibitors of the phosphodiesterase 4 (PDE4) enzyme. More particularly, the invention relates to compounds that are new ester derivatives, methods of preparing such compounds, compositions containing them, and therapeutic uses thereof.
    Type: Grant
    Filed: December 15, 2008
    Date of Patent: June 28, 2011
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Elisabetta Armani, Gabriele Amari, Gino Villetti
  • Patent number: 7838534
    Abstract: Quinuclidine derivative of the general formula (I) in the form of single enantiomers or mixtures thereof are useful in the manufacture of a medicament for the prevention and therapy of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), chronic bronchitis, cough and emphysema wherein: R1 is selected from H, F, Cl, Br, I and (C1-C4)-alkyl; R2 is optionally substituted 2- or 3-thienyl, or substituted phenyl; R3 is (CH2)1-4—COR4 or (CH2)1-4—S(O)nR4, wherein R4 is optionally substituted phenyl or optionally substituted 2- or 3-thienyl; n is 0, 1 or 2; X? is a pharmaceutically acceptable anion.
    Type: Grant
    Filed: July 25, 2007
    Date of Patent: November 23, 2010
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Gabriele Amari, Andrea Rizzi, Riccardo Patacchini, Valentina Cenacchi, Gino Villetti, Juan Lorenzo Catena Ruiz, Isabel Masip Masip
  • Publication number: 20100099768
    Abstract: 1-Phenylalkanecarboxylic acid derivatives, the processes for the preparation thereof and the use thereof in the treatment and/or prevention of neurodegenerative diseases such as Alzheimer's disease.
    Type: Application
    Filed: December 24, 2009
    Publication date: April 22, 2010
    Applicant: Chiesi Farmaceutici S.p.A.
    Inventors: Luca RAVEGLIA, Ilaria Peretto, Stefano Radaelli, Bruno Pietro Imbimbo, Andrea Rizzi, Gino Villetti
  • Patent number: 7662995
    Abstract: 1-Phenylalkanecarboxylic acid derivatives, the processes for the preparation thereof and the use thereof in the treatment and/or prevention of neurodegenerative diseases such as Alzheimer's disease.
    Type: Grant
    Filed: February 19, 2004
    Date of Patent: February 16, 2010
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Luca Raveglia, Ilaria Peretto, Stefano Radaelli, Bruno Pietro Imbimbo, Andrea Rizzi, Gino Villetti
  • Publication number: 20100028353
    Abstract: Polypeptide based on a tandem array of repeats of the N-terminal 7 amino acids of A?42, preferably positioned within the active loop site of a carrier such as bacterial thioredoxin (Trx) are useful for treating and/or preventing Alzheimer's disease. Antibodies raised against these recombinant constructs were found to have a very strong affinity for A?42.
    Type: Application
    Filed: July 15, 2009
    Publication date: February 4, 2010
    Applicant: Chiesi Farmaceutici S.p.A.
    Inventors: Bruno Pietro Imbimbo, Simone Ottonello, Gino Villetti, Nadia Moretto